John Cipriano
Fortuna: 3 240 $ al 31/05/2026
Fortuna: 3 240 $ al 31/05/2026
John Cipriano currently works at CEL-SCI Corp., as Senior Vice President-Regulatory Affairs from 2009.
Mr. Cipriano also formerly worked at US Food & Drug Administration, as Deputy Director-Biologics Investigational New Drug and CEL-SCI Corp., as Senior Vice President-Regulatory Affairs from 2004 to 2008.
Mr. Cipriano received his undergraduate degree from Massachusetts College of Pharmacy & Health Science and graduate degree from Purdue University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CEL-SCI CORPORATION 0,01 % | 09/12/2025 | 2.104 ( 0,01 % ) | 3 240 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CEL-SCI CORPORATION | Consejero General | 01/10/2009 |
| Empresas | Cargo | Fin |
|---|---|---|
| CEL-SCI CORPORATION | Consejero General | 03/12/2008 |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
CEL-SCI Corp.
CEL-SCI Corp. BiotechnologyHealth Technology Provides immunotherapy products for the treatment of cancer and infectious diseases | Health Technology |
Massachusetts College of Pharmacy & Health Science
Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.